Trademarkia Logo

Australia

AU$
KYPROLIS
Registered: Registered/protected

Last updated on 22 Nov 2022

Owner Info

Onyx Pharmaceuticals, Inc a Delaware corporation

249 E. Grand Avenue

South San Francisco 94080 California, UNITED STATES OF AMERICA

Serial Number

1530499 filed on 10 Dec 2012

Correspondent

Davies Collison Cave Pty Ltd

Level 4,

7 Macquarie Place,

Sydney, NSW, 2000 AUSTRALIA

KYPROLIS

Classification Information


Class [005]
Pharmaceuticals

Class [042]
Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the f Read More

Mark Details


Serial Number

1530499

Registered On

10 Dec 2012

Renewal On

10 Dec 2032

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

12 Jul 2012

Mark Type

US

Legal History


Show more

Status DateAction Taken
22nd Nov 2022IP Right Renewed correspondence sent
22nd Nov 2022Renewal Requested
10th Oct 2022Renewal Reminder correspondence sent
2th May 2013IP Right Registration Published
18th Apr 2013Application Status
18th Apr 2013Register Trade Mark
29th Jan 2013Registration fee (2 classes)
10th Jan 2013IP Right Acceptance Published
10th Jan 2013IP Right Filed Published
6th Jan 2013Application Accepted correspondence sent